Loading...
Mixed Asset Passive

KBSTAR Healthcare Fixed Income Balanced (253290)

Update : 2023.11.29

NAV

11,074KRW

+62.41상승 (0.57%)

Market Price per share (KRW)

11,070KRW

+70상승 (0.64%)

※ t-1 last price

trading volume

719shares

AUM

KRW 13.2billion

KBSTAR Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2023.11.29
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KBSTAR HealthCare FixedIncome Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 13,288,603,642
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,070
※ t-1 last price
11,073 719
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency 다운로드 버튼
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KBSTAR HealthCare FixedIncome Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
13,288,603,642 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,070
※ t-1 last price
11,073
Trading Volume (shares)
719
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2023-11-29
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB04250-2512(22-13) 23.29
2 KTB03125-2606(23-4) 18.85
3 KTB03250-2803(23-1) 14.90
4 KBSTAR HealthCare 10.71
5 F 202312 9.61
6 원화예금 8.41
7 KTB01875-2412(21-10) 3.73
8 Celltrion Healthcare 2.12
9 Celltrion 2.06
10 SAMSUNG BIOLOGICS 1.94

proportion by sectors

*The proportion of investment stocks

Update : 2023.11.29
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11
2021-06-09 2021-06-11 10

Performance

performance

excel download

Update : 2023-11-29

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 3.97 1.07 0.35 4.40 -10.89 4.50 12.49
Benchmark Index 4.13 1.35 0.91 5.57 -8.98 5.70 16.71
Outperformance -0.16 -0.29 -0.57 -1.17 -1.91 -1.21 -4.23

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2023.11.28 11,070 0.636상승 11,073.84 0.566상승
2023.11.27 11,000 -0.587하락 11,011.43 -0.400하락
2023.11.24 11,065 -0.315하락 11,054.58 -0.436하락
2023.11.23 11,100 0.180상승 11,103.03 0.291상승
2023.11.22 11,080 -0.045하락 11,070.8 -0.137하락
2023.11.21 11,085 0.498상승 11,086.06 0.401상승
2023.11.20 11,030 0.227상승 11,041.72 0.320상승
2023.11.17 11,005 -0.136하락 11,005.25 -0.207하락
2023.11.16 11,020 0.272상승 11,028.13 0.262상승
2023.11.15 10,990 0.871상승 10,999.27 0.873상승
2023.11.14 10,895 0.322상승 10,904.02 0.356상승
2023.11.13 10,860 -0.229하락 10,865.27 -0.326하락
2023.11.10 10,885 -0.548하락 10,899.68 -0.384하락
2023.11.09 10,945 -0.273하락 10,941.71 -0.297하락
2023.11.08 10,975 0.503상승 10,974.31 0.410상승
2023.11.07 10,920 -0.273하락 10,929.44 -0.335하락
2023.11.06 10,950 1.955상승 10,966.21 1.925상승
2023.11.03 10,740 -0.232하락 10,757.83 0.014상승
2023.11.02 10,765 0.937상승 10,756.31 0.893상승
2023.11.01 10,665 0.140상승 10,661.1 0.215상승
2023.10.31 10,650 -0.187하락 10,638.15 -0.302하락
2023.10.30 10,670 0.329상승 10,670.41 0.177상승

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 KTB04250-2512(22-13) KR103501GCC0 500,000,000 23.29 515,795,000
2 KTB03125-2606(23-4) KR103501GD65 416,666,667 18.85 417,537,083
3 KTB03250-2803(23-1) KR103501GD32 333,333,333 14.9 330,059,999
4 KBSTAR HealthCare KR7253280002 21,141 10.71 237,096,315
5 F 202312 KR4165TC0001 2.05 9.61 212,790,000
6 원화예금 KRD010010001 186,301,099 8.41 186,301,099
7 KTB01875-2412(21-10) KR103501GBC2 83,333,333 3.73 82,586,333
8 Celltrion Healthcare KR7091990002 644 2.12 46,883,200
9 Celltrion KR7068270008 277 2.06 45,705,000
10 SAMSUNG BIOLOGICS KR7207940008 59 1.94 42,893,000
11 HLB KR7028300002 1,141 1.68 37,139,550
12 Yuhan KR7000100008 530 1.5 33,284,000
13 SKBP KR7326030004 271 1.07 23,604,100
14 HanmiPharm KR7128940004 74 1.03 22,866,000
15 Celltrionph KR7068760008 181 0.67 14,878,200
16 SKBS KR7302440003 211 0.65 14,453,500
17 HANALL BIOPHARMA KR7009420001 351 0.59 12,987,000
18 MedyTox KR7086900008 54 0.55 12,096,000
19 CHONGKUNDANG KR7185750007 78 0.45 9,945,000
20 Hanmi Science KR7008930000 270 0.44 9,774,000
21 SCD KR7000250001 136 0.43 9,615,200
22 DENTIUM KR7145720009 65 0.38 8,320,000
23 SEEGENE KR7096530001 319 0.33 7,209,400
24 PharmaResearch KR7214450009 61 0.31 6,819,800
25 CLASSYS KR7214150005 171 0.3 6,643,350
26 CHA Biotech KR7085660009 395 0.3 6,549,100
27 BIONEER KR7064550007 221 0.3 6,630,000
28 GC Corp KR7006280002 55 0.29 6,490,000
29 ST Pharm KR7237690003 100 0.28 6,310,000
30 Jeisys Medical KR7287410005 528 0.27 5,998,080
31 HK inno.N KR7195940002 141 0.25 5,647,050
32 DAEWOONG PHARM KR7069620003 45 0.22 4,855,500
33 i-SENS KR7099190001 207 0.21 4,729,950
34 SD Biosensor KR7137310009 361 0.19 4,259,800
35 ShinpoongPharm KR7019170000 329 0.19 4,201,330
36 JWPHARMA KR7001060003 130 0.17 3,802,500
37 HLBPHARMA KR7047920004 244 0.14 3,098,800
38 ILDONG PHARM KR7249420001 161 0.12 2,749,880
39 GC CELL KR7144510005 79 0.11 2,512,200
40 HUMASIS KR7205470008 1,119 0.11 2,327,520
41 VATECH KR7043150002 70 0.1 2,257,500
42 Binex KR7053030003 278 0.1 2,229,560
43 DIO KR7039840004 92 0.09 2,019,400
44 BioNote KR7377740006 332 0.06 1,394,400
45 KUKJEON KR7307750000 190 0.05 1,119,100
46 Aprogen KR7007460009 1,109 0.05 1,093,474
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.